Anthony Koupparis
North Bristol NHS Trust, At Bristol, Southmead Hospital, Age UK
Papers
21
Total Citations
994
H-Index
12
About
Anthony Koupparis is a leading urological surgeon and researcher whose work has fundamentally shaped the evidence base for robot-assisted radical cystectomy (RARC) in bladder cancer treatment. His research sits at the intersection of minimally invasive urological surgery, surgical oncology, and perioperative care, with a particular focus on comparing robotic and open surgical approaches for bladder cancer management. Koupparis is perhaps best known for his role in the landmark iROC randomised controlled trial, whose 2022 publication garnered over 320 citations, providing critical clinical evidence on 90-day morbidity and mortality outcomes following totally intracorporeal robot-assisted cystectomy versus open surgery. His earlier work establishing enhanced recovery protocols within robotic cystectomy programmes, alongside contributions to the EAU Robotic Urology Section Scientific Working Group, has influenced international clinical guidelines and practice standards. Beyond clinical outcomes, Koupparis has contributed meaningfully to health economics through cost-comparison analyses and to technological innovation through requirements elicitation for next-generation robotic platforms. His international collaborative studies examining adoption trends across North American and European centres further demonstrate his global influence. With a body of work collectively accumulating nearly 1,000 citations, Koupparis represents a pivotal figure in advancing minimally invasive bladder cancer surgery toward evidence-based, patient-centred care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10